Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
MTBVAC vs BCG in Newborns
NCT04975178Phase 3Recruiting
- Sponsor
- Biofabri
- Start
- Oct 2022
- Primary completion
- Feb 2029
- Modality
- Live Biotherapeutic Products, Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
A Phase 3 trial of mtbvac in Tuberculosis (TB), sponsored by Biofabri. Started Oct 2022; status: recruiting.
02
Drugs
mtbvac
03
Conditions
Tuberculosis (TB)
Beyond the preview
Go deeper on NCT04975178.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04975178.